Is P3 Health Partners Inc (NASDAQ:PIII) an excellent stock to buy at the moment?

In the latest session, P3 Health Partners Inc (NASDAQ: PIII) closed at $1.03 up 0.98% from its previous closing price of $1.02. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 388213 shares were traded.

Ratios:

For a deeper understanding of P3 Health Partners Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.67 and its Current Ratio is at 0.67. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.65.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on September 01, 2023, initiated with a Buy rating and assigned the stock a target price of $5.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 13 ’23 when Chicago Pacific Founders UGP I bought 90,000 shares for $2.65 per share. The transaction valued at 238,221 led to the insider holds 50,025,442 shares of the business.

Chicago Pacific Founders UGP I bought 90,000 shares of PIII for $236,520 on Sep 12 ’23. The 10% Owner now owns 49,935,442 shares after completing the transaction at $2.63 per share. On Sep 11 ’23, another insider, Chicago Pacific Founders UGP I, who serves as the 10% Owner of the company, bought 90,000 shares for $2.52 each. As a result, the insider paid 227,142 and bolstered with 50,115,442 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PIII now has a Market Capitalization of 117.55M and an Enterprise Value of 186.79M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.10 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at 0.16 whereas that against EBITDA is -0.34.

Stock Price History:

Over the past 52 weeks, PIII has reached a high of $5.56, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.0720, while the 200-Day Moving Average is calculated to be 1.6852.

Shares Statistics:

For the past three months, PIII has traded an average of 386.68K shares per day and 356.34k over the past ten days. A total of 115.24M shares are outstanding, with a floating share count of 47.73M. Insiders hold about 58.59% of the company’s shares, while institutions hold 18.88% stake in the company. Shares short for PIII as of Mar 15, 2024 were 2.05M with a Short Ratio of 5.30, compared to 2.39M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.78% and a Short% of Float of 5.86%.

Earnings Estimates

There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.19, while EPS last year was -$2.26. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.03 and low estimates of -$0.15.

Analysts are recommending an EPS of between -$0.4 and -$1.13 for the fiscal current year, implying an average EPS of -$0.66. EPS for the following year is -$0.26, with 4 analysts recommending between -$0.04 and -$0.54.

Revenue Estimates

A total of 5 analysts believe the company’s revenue will be $302.97M this quarter.It ranges from a high estimate of $309.8M to a low estimate of $300M. As of the current estimate, P3 Health Partners Inc’s year-ago sales were $258.2M, an estimated increase of 17.30% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $345.43M, an increase of 14.40% less than the figure of $17.30% in the same quarter last year. There is a high estimate of $354.8M for the next quarter, whereas the lowest estimate is $329M.

A total of 5 analysts have provided revenue estimates for PIII’s current fiscal year. The highest revenue estimate was $1.23B, while the lowest revenue estimate was $1.22B, resulting in an average revenue estimate of $1.22B. In the same quarter a year ago, actual revenue was $1.05B, up 16.50% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $1.42B in the next fiscal year. The high estimate is $1.47B and the low estimate is $1.36B. The average revenue growth estimate for next year is up 16.50% from the average revenue estimate for this year.

Most Popular